A detailed history of Baron Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Baron Financial Group, LLC holds 1,268 shares of ABBV stock, worth $222,381. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,268
Previous 1,268 -0.0%
Holding current value
$222,381
Previous $217,000 15.21%
% of portfolio
0.15%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$154.79 - $180.76 $19,348 - $22,595
-125 Reduced 8.97%
1,268 $217,000
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $186,090 - $215,427
1,393 New
1,393 $207,000
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $197,783 - $237,194
1,430 New
1,430 $0
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $119,672 - $140,456
1,393 New
1,393 $122,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Baron Financial Group, LLC Portfolio

Follow Baron Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baron Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baron Financial Group, LLC with notifications on news.